Chromoblastomycosis: New Perspective on Adjuvant Treatment with Acitretin

Chromoblastomycosis: New Perspective on Adjuvant Treatment with Acitretin

Chromoblastomycosis (CBM) is a neglected human disease, caused by different species of pigmented dematiaceous fungi that cause granulomatous and suppurative dermatosis. This infection is difficult to treat and there are limited therapeutic options, including terbinafine, itraconazole, and tioconazol...

Full description

Bibliographic Details
Main Authors: Walter Belda, Luiz Felipe Domingues Passero, Caroline Heleno Chagas de Carvalho, Paula Celeste Rubiano Mojica, Pablo Andrade Vale
Format: Article
Language:English
Published: MDPI AG 2023-11-01
Series:Diseases
Subjects:
chromoblastomycosis
treatment
acitretin
imiquimod
Online Access:https://www.mdpi.com/2079-9721/11/4/162

Similar Items

Similar Items